Literature DB >> 8775874

Families' experiences in consenting to eye donation of a recently deceased relative.

J J Doering1.   

Abstract

OBJECTIVE: To explore the unique experience of families who have consented to eye donation of a recently deceased relative.
DESIGN: Exploratory-descriptive.
SETTING: A city in western Canada. PARTICIPANTS: Seventeen relatives of 16 eye donors who had died within the previous 3 to 12 months.
RESULTS: Families were in psychologic shock after the donor's death, which inhibited their recollection of events. Nurses were found to initiate the possibility of eye donation most often, and the decision to donate was made precipitously. In several cases, it was not stated clearly on the consent form what tissue was to be removed, and whether the family had agreed only to transplantation or transplantation and research. When the tissue was used for research, families had a need to believe this would eventually benefit someone.
CONCLUSION: Particular care needs to be taken when reviewing the consent form with families to ensure that it reflects how they or the donor want the tissue to be used. Families can be prepared for the eventuality that the tissue will be used for research rather than transplantation by the reinforcement that the knowledge gained will help many individuals.

Entities:  

Mesh:

Year:  1996        PMID: 8775874     DOI: 10.1016/s0147-9563(96)80016-1

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  2 in total

1.  Successful Implementation of a Program for Increasing Donor Eyes for Research: The Duke-Miracles In Sight Program.

Authors:  Andrew M Williams; Kristin M Perkumas; Isaac Perry; Joanne C Wen; Janet Keeling; Michael Tramber; Paloma B Liton; W Daniel Stamer
Journal:  J Ocul Pharmacol Ther       Date:  2016-01-28       Impact factor: 2.671

2.  How context affects people's willingness to register for the deceased organ donation programme.

Authors:  Lamia AlHajri; Amna AlHebsi; Maryam AlSuwaidi
Journal:  BMC Public Health       Date:  2021-04-15       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.